Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands

Waltham, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that is has extended a long-term supply agreement with Purolite Life Sciences for the manufacture of Protein A ligands at Repligen’s facilities in Waltham, MA and Lund, Sweden. Repligen is the main strategic supplier of Protein A ligands to Purolite, an emerging player in the Protein A resin market with its Praesto® line of modern agarose-based, high-flow chromatography resins. Pursuant to the agreement, Repligen will supply Protein A ligands to Purolite through November 2022, with an option for renewal through 2025. Protein A chromatography remains the gold standard for monoclonal antibody purification, consistently providing outstanding results.